SCHEMBL2409354

SCHEMBL2409354

Cc1cc(-n2cnc3cnc(N4CCCCC4)nc32)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.44
▸ ESR2 Q92731 2/20 0.44
▸ RPS6KA3 P51812 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ CYP1A2 P05177 6/20 0.38
▸ HSD17B10 Q99714 6/20 0.38
▸ USP2 O75604 4/20 0.38
▸ CASP1 P29466 4/20 0.37
▸ CASP7 P55210 3/20 0.37
▸ HPGD P15428 4/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ JAK3 P52333 1/20 0.36
▸ BTK Q06187 1/20 0.36
▸ GBA1 P04062 1/20 0.36
▸ NT5E P21589 1/20 0.35
▸ MAP3K8 P41279 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2407675 0.99 ESR1 (0.45) ESR1ESR2RPS6KA3POLBSMN1; SMN2
SCHEMBL2409390 0.87 JAK3 (0.47) ESR1ESR2RPS6KA3ALDH1A1CYP1A2
SCHEMBL2408100 0.83 RPS6KA3 (0.47) ESR1ESR2RPS6KA3POLBSMN1; SMN2
SCHEMBL2408379 0.82 RPS6KA3 (0.48) ESR1ESR2RPS6KA3ALDH1A1CYP1A2
SCHEMBL2408819 0.78 ESR1 (0.52) ESR1ESR2RPS6KA3JAK3BTK
SCHEMBL2408719 0.76 ROCK2 (0.44) CYP3A4MAP3K8
SCHEMBL2414403 0.76 MAP3K8 (0.41) RPS6KA3ALDH1A1HSD17B10BTKMAP3K8
SCHEMBL2407161 0.76 ESR1 (0.47) ESR1ESR2RPS6KA3ALDH1A1CYP1A2
SCHEMBL2410911 0.76 CFTR (0.45) RPS6KA3POLBSMN1; SMN2ALDH1A1CYP1A2
SCHEMBL2408774 0.76 HPGD (0.41) POLBSMN1; SMN2ALDH1A1CYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO claimed
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO disclosed
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO disclosed
Send feedback